In the case of a cold, influenza infections or other physical ailments, the first route usually leads primarily to the pharmacy. As the share of Internet users is constantly increasing, the e-pharma business is also becoming more and more popular. This entails some dangers and risks. Furthermore global trade in counterfeit and illicit medicines is growing. The online commerce is also playing an increasingly important role in the realization of the internal market within the EU. Existing and abolished mail order bans in Austria and Germany are examined on the basis of the "DocMorris" decision and subjected to a legal analysis. The Austrian legislature has changed its current legal situation to the effect that this now corresponds to the jurisprudence of the ECJ in the "DocMorris" judgment. In addition, the e-pharma business and the current extent of the counterfeiting as well as the criminality of the defaults are described in more detail. On the basis of the Keck case law, it is shown when the national mail order bans constitute a market entry barrier.